Loss of human epidermal receptor-2 in human epidermal receptor-2+ breast cancer after neoadjuvant treatment: A case report

doi:10.12998/wjcc.v10.i17.5923

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3028)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

201

WORD

HTML

1494

Figures (1-2)

344

Sum=2113

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

222

Download

693

Sum=915

Jun 16, 2022 (publication date) through Jan 17, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jun 16, 2022; 10(17): 5923-5928
Published online Jun 16, 2022. doi: 10.12998/wjcc.v10.i17.5923

Full Size Figure Download Figure

Figure 2 The fluorescence in situ hybridization results after neoadjuvant treatment.

Citation: Yu J, Li NL. Loss of human epidermal receptor-2 in human epidermal receptor-2+ breast cancer after neoadjuvant treatment: A case report. World J Clin Cases 2022; 10(17): 5923-5928
URL: https://www.wjgnet.com/2307-8960/full/v10/i17/5923.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i17.5923